Previous Article | Next Article 
Molecular and Cellular Biology, November 2001, p. 7523-7534, Vol. 21, No. 21
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.21.7523-7534.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
TAFII170 Interacts with the Concave
Surface of TATA-Binding Protein To Inhibit Its DNA Binding
Activity
Lloyd A.
Pereira,
Jan A.
van der Knaap,
Vincent
van den
Boom,
Fiona A. J.
van den Heuvel,§ and
H. T. Marc
Timmers*
Department of Physiological Chemistry,
University Medical Center Utrecht, 3508 AB Utrecht, The Netherlands
Received 11 June 2001/Returned for modification 9 July
2001/Accepted 6 August 2001
 |
ABSTRACT |
The human RNA polymerase II transcription factor B-TFIID consists
of TATA-binding protein (TBP) and the TBP-associated factor (TAF)
TAFII170 and can rapidly redistribute over promoter DNA. Here we report the identification of human TBP-binding regions in human
TAFII170. We have defined the TBP interaction domain of
TAFII170 within three amino-terminal regions: residues 2 to 137, 290 to 381, and 380 to 460. Each region contains a pair of Huntington-elongation-A subunit-Tor repeats and exhibits
species-specific interactions with TBP family members. Remarkably, the
altered-specificity TBP mutant (TBPAS) containing a triple
mutation in the concave surface is defective for binding the
TAFII170 amino-terminal region of residues 1 to 504. Furthermore, within this region the TAFII170 residues 290 to 381 can inhibit the interaction between Drosophila TAFII230 (residues 2 to 81) and TBP through competition for
the concave surface of TBP. Biochemical analyses of TBP binding to the
TATA box indicated that TAFII170 region 290-381 inhibits
TBP-DNA complex formation. Importantly, the TBPAS mutant is
less sensitive to TAFII170 inhibition. Collectively, our
results support a mechanism in which TAFII170 induces
high-mobility DNA binding by TBP through reversible interactions with
its concave DNA binding surface.
 |
INTRODUCTION |
Initiation of mRNA synthesis by RNA
polymerase (pol) II requires the basal transcription factors TFIID,
TFIIB, TFIIE, TFIIF, and TFIIH. Recognition of the TATA box within core
pol II promoters by TFIID initiates the assembly of a functional pol II
preinitiation complex. TFIID is a multisubunit complex consisting of
TATA-binding protein (TBP) and at least 10 TBP-associated factors
(TAFIIs) ranging in size from 15 to 250 kDa.
TAFIIs play several roles in transcriptional
regulation, serving as coactivators, promoter selectivity factors, or
enzymes that modify surrounding transcriptional proteins
(3). The TBP subunit recognizes the TATA box forming the
TBP-TATA complex (24). Structural studies of the TBP-TATA complex indicate that the
sheets of TBP form a concave undersurface which contacts the minor groove of the TATA box (28, 29).
Of relevance to this study is that the largest
TAFII subunit of TFIID
(dTAFII230 in Drosophila,
hTAFII250 in humans, and
yTAFII145/130 in yeast), can inhibit TBP binding
to the TATA box (11, 31, 33).
dTAFII230 achieves this by interacting with the
concave DNA binding surface of TBP (see references cited above).
Residues 2 to 81 (called TAND I) undergo a disorder-to-order transition upon interaction with TBP. The induced structure of TAND I mimics the
structure of the TATA box when bound to TBP (34). A second N-terminal inhibitory domain (TAND II; residues 82 to 156) blocks the
TBP-TFIIA interaction by competitively binding to helix 2 (H2) on the
convex surface of TBP (10). The orthologous
TAFII subunits from yeast and humans contain
regions which are functionally equivalent to TAND I and TAND II despite
a low degree of primary sequence similarity (33).
TAFII-containing complexes distinct from TFIID
have been described. Examples include the yeast SAGA and human PCAF and
TFTC complexes (3). In addition to these, it has been
reported previously that the majority of TBP in mammalian cell extracts
is present in the B-TFIID complex (49). In this distinct
complex TBP is associated with a single TAFII,
TAFII170 (49, 50). B-TFIID can
support TATA-dependent transcription in reconstituted basal transcription experiments as efficiently as TBP or TFIID
(49). Notably the complex displays several biochemical
properties that make it distinct from traditional TFIID. Firstly, pol
II transcription with B-TFIID is not responsive to activators
(49). Secondly, B-TFIID exhibits dATPase activity that can
be attributed to the TAFII170 subunit
(50). Finally, B-TFIID binds unstably to the TATA box,
which may explain its inability to commit a template for transcription
(49).
hTAFII170 has also been cloned as TAF172
(16; referred to in this paper as
TAFII170). hTAFII170 is the
human ortholog of yMot1 (16, 50), and both are members of
the SNF2 family of DNA-dependent ATPases (42).
MOT1 was originally identified by genetic screens for
enhanced basal transcription in yeast (20). Independent
studies showed Mot1 protein to exist in a complex with TBP distinct
from yTFIID (43). Mot1 protein was identified as an
ATP-dependent inhibitor activity in yeast nuclear extracts that removed
TBP from the TATA box using the energy of ATP hydrolysis (6). Interestingly, amounts of Mot1 stoichiometric to TBP
weakly stimulate TBP-dependent transcription, whereas a molar excess of
Mot1 leads to a repression of transcription (17, 36,
39). Studies with Mot1 have shown that the release of TBP
from DNA does not appear to involve an ATP-dependent DNA tracking over distances as short as 40 bp (2, 7). Furthermore,
Mot1-catalyzed disruption of TBP-DNA complexes does not appear to
involve DNA strand separation, DNA bending, or twisting of the helix
(2, 7). Rather, it has been proposed that Mot1 displaces
TBP from DNA by translocation through the TATA box in an ATP-dependent manner (2, 7). Deletion analysis shows that this function requires a 17-bp double-stranded DNA "handle" upstream of the TATA
box, indicating that Mot1 contacts upstream DNA (19).
Several observations indicate that Mot1 interacts with H2 on the convex surface of yTBP (1, 5, 6, 15), which led to the hypothesis that Mot1 can also distort TBP conformation in a "power stroke" action leading to TBP-TATA dissociation (2, 8). However, to date there have been no experimental data to support this. Besides
Mot1 being a repressor of transcription, there is also a link
between Mot1 and activation of transcription. Mot1 may activate
transcription by redistributing a limiting pool of TBP between DNA
sites in vitro and in vivo (17, 36, 39). Notably, TAFII170, like Mot1, uses the energy of ATP
hydrolysis to dissociate TBP from DNA (16).
An important issue is the observation that in contrast to TBP or TFIID,
B-TFIID does not form highly stable complexes with the TATA box in the
absence of ATP (49). We therefore set out to establish how
the hTAFII170/hTBP interaction relates
mechanistically to the TATA box-binding properties of B-TFIID. We first
sought to establish the hTBP interaction domain of
hTAFII170 and show that three regions within the
amino-terminal third of hTAFII170 are involved in
the interaction. We found that these regions are critical for the
binding of hTAFII170 to hTBP and exhibit
species-specific interactions with TBP family members. Strikingly, the
concave DNA binding surface of hTBP is crucial for this interaction.
This led to the finding that a small domain of
hTAFII170 within its amino-terminal part could
inhibit TBP-TATA complex formation. Our results support a model in
which insertion of this hTAFII170 domain into the
DNA binding cavity of hTBP inhibits its interaction with the TATA box
and explains the DNA binding properties of B-TFIID. Reversibility of
this process would allow for rapid redistribution and increased
mobility of hTBP on DNA.
 |
MATERIALS AND METHODS |
Plasmids.
pJGhTBP was created by cloning a SalI
(blunt)-XhoI fragment from pRSVhIID into the
EcoRI (blunt) and XhoI sites of pJG4-5. pJGTBPAS was generated by cloning a
DraIII-ClaI fragment from pSRaMSVtkneohTBPm3e
(14) into the DraIII and ClaI sites
of pJGTBP. To create the pEG202-hTAFII170
derivatives NdeI-AocI (1-504), BamHI-AocI (136-504), BspHI
(1133-1849), and XmaI (blunt)-BspHI (505-1133),
fragments from hTAFII170 cDNA were cloned into
pEG202. The remaining pEG-hTAFII170 plasmids were
created from pEG-hTAFII170 (1-504) by using a
double-stranded, nested-deletion kit (Pharmacia Biotech). pAC-TAF
(2-460) was created by cloning a PCR fragment generated from
hTAFII170 cDNA into the XhoI and
NotI (blunt) sites of pACYC. All other
pAC-hTAFII170 constructs were created by cloning PCR fragments amplified from pAC-TAF (2-460) into the SpeI
and XhoI sites of pAC-TAF (2-460). To generate glutathione
S-transferase (GST)-Flag-TAF fusions,
NdeI-SpeI fragments from
pAC-hTAFII170 derivatives were cloned into the
NdeI and SpeI sites of modified pGEX-2T. To
prepare His-tagged dTAFII230 (2-81),
dTAFII230 (82-156), and
dTAFII230 (2-156), corresponding DNA from
pGEX-dTAFII230 (2-156) (a kind gift from Y. Nakatani) was PCR amplified as SalI-BamHI fragments and subcloned into pET15b (Novagen). pGST-TFIIS was created
by cloning an NdeI-BamHI fragment from
pET22-TFIIS (a kind gift from C. Kane) into the NdeI and
BamHI sites of pGEX-2T. For expression of full-length
hTAFII170 in mammalian cells,
pMT2-hTAFII170 was created by cloning a
NaeI-StuI fragment from
pET-hTAFII170 into the SmaI site of
pMT2-SM. pSG-ehTBP and pSG-ehTBPm3e (kind gifts from H. Stunnenberg)
and pSG-ehTBPK243E were used for expression of full-length hTBP in
mammalian cells (see Fig. 5B). pSG-ehTBPK243E was created by
oligonucleotide-mediated, site-directed mutagenesis using pSG-ehTBP as
the template.
Yeast two-hybrid analysis.
Yeast strain EGY48 was
transformed with the hTAFII170 derivatives
harbored in the bait vector pEG202, either pJG-hTBP or
pJG-hTBPAS accompanied by pSH18-34 (Invitrogen)
harboring the lacZ reporter in accordance with the standard
lithium acetate method (9). Transformants were selected on
His/Trp/Ura-deficient plates and patched onto His/Trp/Ura/Leu-deficient
plates containing
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal) and galactose. Interactions were scored by measurement of
growth of blue colonies and quantitative determination of
-galactosidase activity as described previously (38).
Protein expression.
Escherichia coli strain
BL21(DE3) containing pGEX-hTBP, pGEX-TFIIS,
pGEX-Flag-hTAFII170 derivatives,
pET15b-dTAFII230 derivatives, or
pAC-hTAFII170 derivatives was cultured at 37°C
in 50 ml of Luria-Bertani medium containing ampicillin (100 µg/ml)
or, in the case of pAC-hTAFII170 derivatives,
chloramphenicol (25 µg/ml). At an optical density at 600 nm of 0.5 to
0.6, the cells were induced with
isopropyl-
-D-thiogalactopyranoside (IPTG) (0.4 mM). After 3 h cells were harvested and the cell pellet was
resuspended in 4 ml of lysis buffer (50 mM Tris-HCl, pH 8.0, 20%
sucrose, 1 mM EDTA, 0.3 M KCl, 0.01% Triton X-100, 1 mM
dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride [PMSF], 0.2 mM
sodium metabisulfite, 1 µg of aprotinin/ml, and 1 µg of
leupeptin/ml). The cells were incubated on ice with 200 µg of
lysozyme/ml and lysed by freeze-thawing and sonication, and the
bacterial lysate was cleared by ultracentrifugation.
Purification of GST-Flag-hTAFII170,
His-dTAFII230 derivatives, and hTBP proteins.
GST-Flag-TAFII170-containing lysates were
prepared on a 2-liter scale as described above and loaded onto a
glutathione agarose column. The column was washed with lysis buffer (20 mM HEPES-KOH, pH 8.05, 20% glycerol, 300 mM KCl, 0.01% Triton X-100,
1 mM EDTA, and protease inhibitors) and eluted with lysis buffer
containing 15 mM glutathione. Peak fractions were pooled and dialyzed
against A100 buffer (20 mM HEPES-KOH, pH 7.9, 20% glycerol, 100 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol, and 0.5 mM
PMSF). The amount of eluted protein was determined by Bio-Rad protein
assays (Bio-Rad) using bovine gamma globulin as a standard and
Coomassie blue staining of sodium dodecyl sulfate (SDS)-polyacrylamide
gel electrophoresis gels. Proteins were negative for RNase activity as
analyzed by incubation with radiolabeled RNA.
His-dTAFII230 derivatives were batch purified by
mixing clarified lysates containing 20 mM imidazole with
Ni-nitrilotriacetic acid agarose (Qiagen) for 2 h at 4°C with
gentle shaking. The slurry was washed two times in wash buffer (50 mM
Tris-HCl, pH 8.0, 20% sucrose, 1 mM EDTA, 0.3 M KCl, 0.01% Triton
X-100, 20 mM imidazole, 0.5 mM PMSF, 0.2 mM sodium metabisulfite, 1 µg of aprotinin/ml, and 1 µg of leupeptin/ml), and the
His-dTAFII230 proteins were eluted in wash buffer
containing 300 mM imidazole for 30 min at 4°C with gentle shaking.
His-hTBP was expressed in E. coli and purified as
described previously (26). For Fig. 6C, recombinant hTBP
and altered- or relaxed-specificity hTBP (hTBPAS)
were expressed as GST fusions in E. coli and
purified as described for the GST-Flag-TAFII170
derivatives, with the following modifications: after glutathione
agarose chromatography, peak hTBP fractions, as judged by Coomassie
staining of protein gels, were pooled and the GST tag was removed by
cleaving the pooled hTBP preparations with thrombin (1 IU/0.8 mg of
protein) for 4 h at 37°C. Thrombin was removed by batch
purifying the hTBP preparations with benzamidine Sepharose 6B (Sigma).
The preparations were dialyzed against A100 buffer and
subsequently batch purified with glutathione agarose to remove GST and
uncleaved hTBP fusion protein. The preparations were then applied to a
5-ml HiTrap heparin cartridge (Pharmacia Biotech). The column was
developed by a linear gradient from 0.1 to 1.0 M KCl in buffer A over
10 column volumes. hTBP fractions with the highest specific activity,
as judged by gel shift analysis, were used for subsequent experiments.
GST fusion protein interactions.
To analyze interactions
between hTAFII170 and hTBP or TBP family members,
bacterial lysates containing equivalent levels of Flag-hTAFII170 derivatives were incubated with
bacterial lysate containing equivalent levels of GST-TBPs or GST-TFIIS
and 100 µl of prewashed glutathione beads in 500 µl of binding
buffer (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 20% glycerol, 300 mM KCl
[unless otherwise indicated], 0.01% Triton X-100, and protease
inhibitors). Reactions were performed at 4°C for 3 h with
rotation. Complexes were washed in binding buffer eluted in SDS sample
buffer, and Flag-tagged hTAFII170 proteins were
analyzed by Western blotting with
Flag M2 (Kodak). For analysis of
hTAFII170 and His-hTBP interactions, bacterial
lysates containing equivalent levels of GST-Flag-hTAFII170 derivatives or GST-TFIIS were
incubated with His-hTBP (460 ng) as described above. His-hTBP was
analyzed by Western blotting with 20C7 (
-TBP). To examine
interactions between GST-Flag-hTAFII170,
His-hTBP, and His-dTAFII230 derivatives,
bacterial lysates containing equivalent levels of
GST-Flag-hTAFII170 derivatives were incubated
with His-hTBP (72 ng) and 180, 60, 20, and 6.6 pmol of batch-purified
His-dTAFII230 TAND I or II lysate or 60, 20, 6.6, and 2.2 pmol of batch-purified His-dTAFII230 TAND
I and II lysate as described above. His-hTBP was analyzed by Western blotting with 20C7 (
-TBP).
Coimmunoprecipitation analysis.
COS-7 cells at approximately
70% confluency were washed in phosphate-buffered saline; resuspended
with 5 µg of pSG-ehTBP, pSG-ehTBPm3e, or pSG-ehTBPK243E and 15 µg
of pMT2-hTAFII170; and electroporated with a
1.2-kV pulse at 25 µF (gene pulser; Bio-Rad). After transfection (48 h) cells were lysed in ELB buffer (50 mM HEPES-KOH, pH 7.9, 150 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 0.1%
NP-40, 1 mM
-mercaptoethanol, and protease inhibitors). For
coimmunoprecipitation, COS-7 cell lysates were incubated in ELB buffer
with 10 µg of
-TBP (1F8) or 10 µg of
-c-Myc (9E10) with
rotation at 4°C. After 4 h, prewashed protein G beads were added
to recover immunoprecipitates and were washed in ELB buffer and
hTAFII170 proteins were analyzed by Western
blotting with 5115 (
-TAFII170)
(50).
Protein-DNA interaction assays.
Gel mobility shifts were
performed with 5,000 cpm (approximately 0.1 ng) of
32P-labeled adenovirus major late promoter
(AdMLP) probe (
53 to +33), 0.2 pmol of His-hTBP or GST-cleaved TBPs,
160 ng of partially purified hTFIIA, and purified
GST-Flag-hTAFII170 derivatives for 30 min at
30°C in a buffer containing 18.5 mM HEPES-KOH, pH 7.9, 18.5%
glycerol, 5 mM MgCl2, 0.5 mM EDTA, 50 µg of
poly(dG-dC)/ml, 0.2 mg of bovine serum albumin/ml, and 60 to 80 mM KCl. Reactions were resolved on a 4% Tris-glycine gel. DNase I
footprinting was performed with 12,500 cpm (approximately 0.5 ng) of
32P-labeled AdMLP probe (
17 to +33), purified
GST-Flag-hTAFII170 derivatives, and 6.0 pmol of
His-hTBP under standard gel shift conditions. DNase I (1.5 U) was added
and the reactions were incubated for 1 min. DNase I was inactivated by
addition of an equal volume of stop mix (2% SDS, 200 mM EDTA). DNA was
recovered by ethyl alcohol precipitation and analyzed on a 6%
urea-Tris-borate-EDTA gel.
In vitro transcription.
Transcription reactions using 25 ng
of linearized template pAdML(C2AT)
400 were
performed as previously described (49). Reactions
contained bacterially derived His-hTBP (0.24 pmol), TFIIB (60 ng),
TFIIE (150 ng), purified GST-Flag-hTAFII170
derivatives and baculovirus-expressed TFIIF (40 ng), purified HeLa
cell-derived TFIIH (0.5 µl), and calf thymus RNA pol II (0.4 µl).
Purification of transcription factors was performed as previously
described (26). RNA was recovered as previously described
(49). Recovery control RNA was synthesized as
described above from linearized pAdML(C2AT)
200.
 |
RESULTS |
The amino terminus of hTAFII170 interacts with
hTBP.
Determining interaction surfaces within the B-TFIID complex
is hampered because B-TFIID cannot be efficiently reconstituted from
its isolated components (16, 50). Therefore, we exploited the yeast two-hybrid system to reconstitute hTBP and
hTAFII170 interactions in vivo. Full-length
hTAFII170 is not expressed efficiently as a LexA
fusion in yeast. Therefore, three LexA DNA binding domain fusion
constructs spanning hTAFII170 (residues 1 to 504, 505 to 1133, and 1133 to 1849) were constructed and tested for
interaction with hTBP fused to the B42 activation domain (Fig.
1A). The 1-504 construct shows a strong
interaction with hTBP in contrast to the 505-1133 and 1133-1849 constructs (Fig. 1A). Region 1-455 is sufficient for hTBP interaction,
but continued deletions result in hTAFII170
fusions that activate transcription in the absence of exogenous
B42-hTBP (Fig. 1A and data not shown). Nevertheless, with the 1-359 construct, an interaction with hTBP was still seen above this
background (Fig. 1A). Deletion of the first 135 residues results in a
twofold decrease in hTBP interaction (Fig. 1A). Western blot analysis
confirmed that all LexA-hTAFII170 deletion
mutants that failed to interact with hTBP were expressed (Fig. 1B,
lanes 1 to 4) and resided in the nucleus as indicated by the JK101
repression test (data not shown). Thus, the yeast two-hybrid analysis
of the hTAFII170-hTBP interaction indicates that
amino-terminal residues 1 to 504 of hTAFII170 are
important for the interaction with hTBP. This agrees with deletion
studies of Mot1 which showed that the first 1,200 amino-terminal
residues are involved in contacting DNA-bound yTBP (8)
while the first 800 amino-terminal residues can contact free yTBP
(1).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
Interaction of hTAFII170 with hTBP and
hTBPAS in the yeast two-hybrid system. (A) Schematic
representation of the various LexA-hTAFII170 deletion
mutants and relative -galactosidase activities. Yeast strain EGY48
was transformed with the indicated LexA-hTAFII170
expression plasmids and B42-hTBP or B42-hTBPAS expression
plasmids together with a lacZ reporter gene containing
LexA operators. -Galactosidase activities were expressed as fold
activation relative to the -galactosidase activity of yeast cells
expressing the LexA fusion and the unfused B42 activation domain only.
Quantifications were performed in triplicate. ND, not determined. (B)
Expression of LexA-hTAFII170 derivatives in yeast. Yeast
samples containing equal amounts of cells were prepared from cultures
harboring the LexA-hTAFII170 expression plasmids (lanes 1 to 4) and were analyzed using LexA antibodies.
|
|
Three regions in the amino terminus of TAFII170 can
independently bind hTBP.
To avoid self-activation problems in the
yeast two-hybrid system, we developed a direct protein-protein binding
assay to further delineate the hTBP interaction domain of
hTAFII170. A series of amino- and
carboxy-terminal deletion mutants of Flag-tagged
hTAFII170 residues 2 to 460 were analyzed for
their ability to interact with GST-hTBP (Fig.
2A to E). As specificity
controls, binding to a GST fusion of the active part
of the elongation factor hTFIIS (Fig. 2A to E) or to GST alone (data
not shown) was analyzed. Consistent with the yeast two-hybrid data,
region 137-460 is specifically retained by GST-hTBP (Fig. 2A to C, lane
6; D, lane 7; and E, lane 6). Analysis with amino-terminal truncations
revealed that residues up to 336 could be removed without affecting the
interaction with hTBP (Fig. 2A, lanes 6 to 10). Similarly,
carboxy-terminal truncations demonstrated that removal of residues to
361 had no effect (Fig. 2B, lanes 6 to 8). However, deletions extending
to residues 311 abolished the interaction with hTBP (Fig. 2B, lanes 9 and 10). Thus, these analyses define a region of 23 residues between
337 and 360 important for the interaction with hTBP. Consistently, a
more extensive carboxy-terminal deletion removing residues to 347 abolished hTBP-binding activity (Fig. 2C, lane 10).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Mapping domains in the amino terminus of
hTAFII170 required for interaction with hTBP. (A to E) The
schematics represent the hTAFII170 amino- and
carboxy-terminal derivatives. Bacterial lysates containing equivalent
amounts of the Flag-tagged-hTAFII170 derivatives were
analyzed for binding to GST-hTBP (A to D, lanes 6 to 10; E, lanes 5 to
8) or, as a control, to GST-TFIIS (A to D, lanes 11 to 15; E, lanes 9 to 12) as described in Materials and Methods. The input lanes represent
10% of the hTAFII170 proteins used (A to D, lanes 1 to 5;
E, lanes 1 to 4). (F) Bacterial lysates containing the
GST-Flag-hTAFII170 regions (lanes 2 to 5) or, as a control,
GST-TFIIS (lane 6) were tested for binding to His-hTBP (460 ng) as
described in Materials and Methods. The input lane represents 10% of
the hTBP used in the binding reactions (lane 1). (G) Salt sensitivity
of the interaction between the amino terminus of hTAFII170
and hTBP. Bacterial lysates containing
Flag-tagged-hTAFII170 2-460 were analyzed for binding to
GST-hTBP (lanes 2 to 5) or, as a control, GST-TFIIS (lanes 6 to 9) in
the presence of the indicated concentrations of KCl. The input lane
represents 10% of the hTAFII170 protein used.
|
|
Amino-terminal truncations extending to residue 379 revealed binding of
hTBP above background (Fig. 2D, lane 10). Thus,
hTAFII170 appears to have a second region
spanning residues 380 to 460 that is capable of independently
interacting with hTBP. In addition, the yeast two-hybrid analysis
suggested that the extreme amino terminus of
hTAFII170 may also contain a hTBP-binding domain
(Fig. 1A, compare LexA-hTAFII170 1-504 and
LexA-hTAFII170 136-504). We tested this
directly, and this revealed that the first 137 residues are able to
interact with hTBP weakly but consistently (Fig. 2E, lane 8).
The in vitro GST-hTBP binding indicates that the amino-terminal third
of hTAFII170 harbors three regions capable of
binding hTBP. To confirm that these regions can independently interact, GST-Flag-hTAFII170 residues 2 to 460, 2 to 137, 290 to 381, and 380 to 460 were tested for their ability to retain
hTBP. Each of these regions can specifically bind hTBP (Fig. 2F, lanes
2 to 6). Notably, region 290-381 binds hTBP most efficiently with approximately 40% of hTBP retained (Fig. 2F, compare lanes 1 and 4).
These combined results indicate that three regions within the
amino-terminal part of hTAFII170 can interact
with hTBP independently.
The protein-protein binding assays used above were performed with a 300 mM concentration of potassium chloride. The B-TFIID complex is stable
under these conditions, and the initial identification of B-TFIID
relied on gel filtration chromatography performed with 300 mM potassium
chloride (49). In fact, immunopurified
hTBP/hTAFII170 complexes are stable with up to 1 M potassium chloride (16). However, a recent study by
Adamkewicz and colleagues indicated that Mot1 binding to yTBP is
compromised by increasing the ionic strength of the reaction
(1). Therefore, we tested the effect of ionic strength on
the efficiency of the hTAFII170
(2-460)/hTBP interaction. This interaction was not affected by
increasing the salt concentration to 600 mM (Fig. 2G, lanes 2 to 5). In
fact, with 75 mM potassium chloride, the interaction seemed somewhat reduced (Fig. 2G, compare lanes 2 and 4). Analysis of the individual regions 2-137, 290-381, and 380-460 showed the same pattern (data not
shown). This indicates that electrostatic interactions are not the
primary determinants for hTAFII170/hTBP interaction.
Comparison of the hTAFII170 regions extending
from residues 2 to 137, 290 to 381, and 380 to 460 with those of
TAFII170 from Saccharomyces cerevisiae
and Drosophila melanogaster reveals significant similarity
(Fig. 3A). Outside these domains there is
little similarity. Furthermore, these regions are well conserved in the
apparent TAFII170 orthologs in Arabidopsis
thaliana, Schizosaccharomyces pombe, and
Caenorhabditis elegans (data not shown). An iterative search-and-alignment method for repeated protein motifs indicated that
these regions of hTAFII170 and Mot1 share
clusters of tandemly arrayed Huntington elongation-A subunit-TOR (HEAT)
repeats (40). HEAT repeats have been identified in a
variety of proteins of distinct cellular function and can be defined as
degenerate sequences rich in hydrophobic residues that are arranged
into a pair of amphipathic
-helices (22, 40).
Strikingly, the predicted HEAT repeats of
hTAFII170 overlap with its TBP-binding regions, with each containing a pair of HEAT repeats (Fig. 3A and B). Outside these regions, hTAFII170 orthologs display a
lower degree of similarity (16, 50). Collectively, this
suggests that the TBP-binding regions of
hTAFII170 have been conserved during evolution
and that the HEAT repeat motifs mediate TBP interaction.

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 3.
Sequence analysis of the hTBP binding regions of
hTAFII170. (A) Alignment of hTAFII170
amino-terminal residues 2 to 137, 284 to 381, and 380 to 460 with yeast
and Drosophila TAFII170 sequences. White
letters on a black background indicate amino acid identity. The black
bars indicate positions of the putative HEAT repeats (40).
Alignments were performed using the CLUSTAL W algorithm
(48). The sequence for Mot1 and Drosophila
89B helicase was obtained using hTAFII170 amino-terminal
residues 1 to 460 as a query sequence in searches of the yeast and
Drosophila databases with the BLAST Network service. (B)
Alignment of the putative hTAFII170 HEAT repeat motifs
within regions 2 to 137, 284 to 381, and 380 to 460 with the
HEAT/ARM repeat consensus (4, 40). The HEAT/ARM
repeat consensus is derived from sequence alignments of
repeat-containing eukaryotic proteins identified in database searches
and consists of highly conserved hydrophobic residues ( ) at
positions 10, 13, 17, 24, 28, 32, and 35 (4, 40).
Alignments were performed using the CLUSTAL W algorithm
(48).
|
|
The hTAFII170 amino-terminal regions show
species-specific interactions with TBP family members.
The core
region of hTBP is highly conserved throughout evolution
(25). In addition, recent studies have revealed the
existence of the close TBP homologs TBP-like factor (TLF) and
TBP-related factor (TRF) and have demonstrated their importance for the
regulation of transcription (18). This prompted us to
examine if the hTAFII170 amino terminus could
interact with various TBP family members. GST fusions of dTBP, yTBP,
and C. elegans TLF (ceTLF) and dTRF-1 were tested
for their ability to retain the hTAFII170 amino
terminus. The hTAFII170 amino terminus (residues
2 to 460) was specifically retained by yTBP and dTBP with comparable
efficiency to that of hTBP (Fig. 4A;
lanes 2 to 4). In contrast, poor binding to ceTLF was observed (Fig.
4A, lane 5). The hTAFII170 amino terminus also interacted with dTRF-1 but with a slightly lower efficiency than did
hTBP (Fig. 4A, lane 6).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 4.
The hTAFII170 amino-terminal regions show
species-specific interactions with TBP family members. Bacterial
lysates containing GST-TBP family members (lanes 2 to 6) or, as a
control, GST-TFIIS (lane 7) were assayed for binding to the
amino-terminal Flag-hTAFII170 derivatives (A to D) as
described in Materials and Methods. The input lanes represent 10% of
the hTAFII170 proteins used (lane 1).
|
|
We tested whether the hTAFII170 regions 2-137, 290-381, and 380-460 were required for binding between the
hTAFII170 amino terminus and TBP family members.
As expected the regions 2-137, 290-381, and 380-460 could be
specifically retained by hTBP (Fig. 4B to D, lanes 2). Region 2-137 and
290-381 but not 380-460 bound to dTBP (Fig. 4B to D, lanes 3).
Surprisingly, each bound poorly, if at all, to yTBP (Fig. 4B to D,
lanes 4). ceTLF bound poorly to all regions (Fig. 4B to D, lanes 5). In
contrast, region 290-381 bound dTRF-1, but regions 380-460 and 2-137 exhibited poor binding (Fig. 4B to D, lanes 6). Western blot analysis
and Coomassie staining confirmed that all GST fusion proteins were
present in the reactions at comparable levels (data not shown). These
results show that the amino-terminal regions of
hTAFII170 exhibit species-specific interactions
with various TBP family members.
The amino terminus of hTAFII170 interacts with concave
DNA binding surface of hTBP.
Biochemical and genetic evidence
suggests that Mot1 interacts with specific residues on H2 at the convex
surface of yTBP overlapping the TFIIA-binding site (1, 5, 6,
15). To investigate the hTBP determinants for binding
hTAFII170, we planned to test in the yeast
two-hybrid assay hTBP convex surface mutants previously examined for
loss of specific biochemical activities (14). These mutants were generated in the background of
TBPAS. This TBP molecule contains a triple
mutation in its concave surface (I292F, V301T, L303V) resulting in a
relaxed specificity for TATA binding (45). As a control in
the two-hybrid system we tested the interaction between
hTBPAS and the amino terminus of
hTAFII170 (Fig. 1A). To our surprise,
hTBPAS failed to interact with
hTAFII170 regions 1-504 and 136-504 (Fig. 1A).
Western blot analysis indicated that wild-type hTBP and
hTBPAS were expressed to similar levels (data not
shown). This suggests that residues in the concave DNA binding surface
of hTBP are important for interaction with the
TAFII170 amino terminus, so we decided to test
this possibility further.
TAND I (residues 2 to 81) of dTAFII230 blocks
TBP-TATA box binding by direct occupancy of the concave DNA binding
face of TBP, whereas TAND II competes with TFIIA for binding to H2 on the convex surface of TBP (31, 33, 34, 41). To elaborate the interaction between the amino terminus of
hTAFII170 and the concave surface of hTBP, we
tested whether TAND I of dTAFII230 and the
hTAFII170 regions compete in an hTBP-binding
assay. Histidine-tagged TAND I and TAND I and II together, but not TAND
II alone, inhibited the interaction between hTBP and
GST-Flag-hTAFII170 region 290-381 in a
dose-dependent manner (Fig. 5A, lanes 2 to 13). In conclusion, results of the yeast two-hybrid and GST pulldown
assays indicate that the amino terminus of
hTAFII170 contains a region which can bind to the
concave DNA binding surface of hTBP and influences its DNA binding
properties.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 5.
Interaction of full-length hTAFII170 with
the convex and concave surfaces of hTBP. (A) The amino termini of
dTAFII230 (TAND I) and hTAFII170 bind
competitively to hTBP. The bacterial lysate of
GST-Flag-hTAFII170 residues 290 to 381 was incubated with
His-hTBP (2 pmol) in the absence (lane 1) or presence of batch-purified
lysates of His-dTAFII230 (TAND I, residues 2 to 81; lanes 2 to 5), His-dTAFII230 (TAND II, residues 82 to 156; lanes 6 to 9), and His-dTAFII230 (TAND I and II, residues 2 to 156;
lanes 10 to 13) and was assayed for hTBP binding as described in
Materials and Methods. As a control for background binding GST-TFIIS
was incubated with His-hTBP (2 pmol) in the absence of the
His-dTAFII230 TANDs (lane 14). For
His-dTAFII230 TAND I and His-dTAFII230 TAND II,
the titration series of 180, 60, 20, and 6.6 pmol of batch-purified
His-dTAFII230 lysates was used. For
His-dTAFII230 TAND I and II, the titration series of 60, 20, 6.6, and 2.2 pmol of batch-purified His-dTAFII230
lysates was used. (B) Coimmunoprecipitation of exogenously expressed
full-length hTAFII170 and the hTBPK243E and
hTBPAS mutants. Immunoprecipitation from COS-7 cell lysates
was performed with -hTBP (lanes 4 to 6) or, as a control, -c-Myc
(lanes 7 to 9) as described in Materials and Methods. The input lane
represents 20% of the cell extract used in the immunoprecipitations
(lanes 1 to 3). wt, wild type. Asterisks indicate nonspecific bands.
|
|
In light of the observed interactions of Mot1 and
hTAFII170 with the convex surface of TBP, this
was unexpected. Therefore, we addressed this issue by analyzing in our
in vitro GST pulldown assay the binding of hTBP convex mutants to three
identified TBP interaction regions of hTAFII170.
In this assay we failed to observe any effect of convex mutations (data
not shown). Possibly, other regions of hTAFII170
are required for convex interactions. Alternatively, convex contacts
escaped detection because a nonlinear domain is involved. To test this
we used a coimmunoprecipitation assay, employing full-length
hTAFII170. We constructed plasmids expressing either the K243E mutant or the hTBPAS mutant of
hTBP. Mutation K243E lies in H2 on the convex surface of hTBP and
corresponds to yTBP (K145E), which was shown to be defective for
interaction with Mot1 (15). Immunoprecipitates from
cotransfected cell lysates were analyzed for the presence of
hTAFII170 and hTBP (Fig. 5B). Expression of
wild-type hTBP resulted in coprecipitation of
hTAFII170 (Fig. 5B, lane 4). In contrast, the
convex K243E mutant inefficiently coimmunoprecipitated
hTAFII170 (Fig. 5B, lane 5). As expected from our
previous analyses, the concave hTBPAS was
severely compromised in its interaction with
hTAFII170 (Fig. 5B, lane 6). The
coimmunoprecipitation results suggest that, in the context of
full-length hTAFII170, both the convex and
concave surfaces of hTBP are used.
The amino-terminal regions of hTAFII 170 inhibit
hTBP-TATA box interaction.
To address whether the interaction
between the amino-terminal part of hTAFII170 and
the concave surface of hTBP influences the hTBP-TATA interaction, gel
mobility shift analyses with hTBP, TFIIA, and a DNA fragment of the
AdMLP TATA box were performed in the presence of the
hTAFII170 amino-terminal regions. A complex corresponding to hTBP-TFIIA-TATA, TA, could be observed
in the absence of
hTAFII170 (Fig. 6A and B, lanes
1, 6, 11, 17, 22, and 27). Addition of purified
GST-Flag-hTAFII170 region 2-460 or 290-381 simultaneously with the probe, hTBP, and TFIIA inhibited the TA complex
in a dose-dependent manner (Fig. 6A, lanes 2 to 5 and 18 to 21).
Consistent with its strong hTBP-binding activity, region 290-381 efficiently inhibited the TA complex (Fig. 6A, lanes 18 to 21).
However, the TA complex was less efficiently inhibited by region
380-460 (Fig. 6B, lanes 18 to 21) and was unaffected by region 2-137 (Fig. 6B, lanes 2 to 5), both of which bind hTBP weakly. The inhibition
was specific since the GST-Flag-hTAFII170 fusion
proteins had no effect on protein-DNA complexes formed by the E-box
protein, Max (data not shown). Inhibitory effects were also observed if
the hTAFII170 amino-terminal regions were preincubated with hTBP prior to the addition of TFIIA and probe (Fig.
6A and B, lanes 7 to 10 and 23 to 26). Notably, preassembly of the TA
complex rendered it largely refractory to the inhibitory effect of
hTAFII170 regions 2-460, 290-381, and 380-460 (Fig. 6A and B, lanes 12 to 15 and 28 to 31). This is expected because TBP-TATA complexes are relatively stable and, thus, the concave DNA
binding surface is not available after TA complex formation. Similarly,
hTBP-TFIIA-TFIIB-TATA complex formation was also inhibited by the
hTAFII170 regions 2-460 and 290-381 (data not
shown). Together these results indicate that the amino-terminal regions
2-460, 290-381, and, to a lesser extent, 380-460 are capable of
inhibiting the TBP-TATA interaction.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 6.
The amino terminus of hTAFII170 negatively
regulates the TATA box-binding activity of hTBP. (A) Gel mobility
shifts were performed with an AdMLP probe ( 55 to +33) incubated with
no protein (lane 16); with His-hTBP (0.2 pmol) and hTFIIA (lane 1, 6, 11, 17, 22, and 27); with hTBP, hTFIIA, and
GST-Flag-hTAFII170 residues 2 to 460 (lanes 2 to 5, 7 to
10, and 12 to 15); or residues 290 to 381 (lanes 18 to 21, 23 to 26, and 28 to 31). (B) Gel mobility shifts were performed as described for
panel A with no protein (lane 16); His-hTBP and hTFIIA (lane 1, 6, 11, 17, 22, and 27); with hTBP, hTFIIA, and GST-Flag-hTAFII170
residues 2 to 137 (lanes 2 to 5, 7 to 10, and 12 to 15); or residues
380 to 460 (lanes 18 to 21, 23 to 26, and 28 to 31). (C) Gel mobility
shifts were performed as described for panel A with no protein (lane
1); hTBP and hTFIIA (lane 2); hTBP, hTFIIA, and
GST-Flag-hTAFII170 residues 2 to 460 (lanes 3 to 8);
hTBPAS and hTFIIA (lane 9); or hTBPAS, hTFIIA,
and GST-Flag-hTAFII170 residues 2 to 460 (lanes 10 to 15).
For panels A and B, an equivalent amount of each
GST-Flag-hTAFII170 protein was used (25.0, 12.5, 6.25, and
3.12 pmol for each titration series). For panel C, 17.0, 13.0, 9.0, 7.0, 5.0, and 3.0 pmol of
GST-Flag-hTAFII170 2-460 protein was used in the titration
series. No preinc, GST-Flag-hTAFII170 was included
simultaneously in reactions with TBP and hTFIIA (lanes 2 to 5 and 18 to
21); Preinc, GST-Flag-hTAFII170 was preincubated with TBP
on ice for 30 min prior to the addition of probe and hTFIIA (lanes 7 to
10 and 23 to 26); Preass, TBP and TFIIA were allowed to form a complex
on the AdMLP before the addition of GST-Flag-hTAFII170
(lanes 12 to 15 and 28 to 31). TA indicates the hTBP-hTFIIA-AdMLP
complex. TASA indicates the hTBPAS-hTFIIA-AdMLP
complex. The asterisks indicate a nonspecific interaction due to
contaminating proteins present in the hTFIIA fractions. FP indicates
free probe.
|
|
Our interaction analysis in yeast and mammalian cells indicated that
mutations at the concave surface of hTBPAS
abolish hTAFII170 interaction (Fig. 1A). This
predicts that DNA complexes formed with this TBP mutant should be less
sensitive to the hTAFII170 amino terminus. To
test this we expressed and purified recombinant hTBPAS protein. Gel shift analysis indicated that
hTBPAS forms a TA complex with an efficiency
equal to that of wild-type hTBP (Fig. 6C, lanes 2 and 9). As expected,
titration of hTAFII170 region 2-460 into the DNA
binding reactions with wild-type hTBP inhibited the TA complex (Fig.
6C, lanes 3 to 8). In contrast, titration of
hTAFII170 region 2-460 into the DNA binding
reactions with hTBPAS failed to significantly
inhibit the TA complex (Fig. 6C, lanes 10 to 15). This finding is
consistent with the conclusion that the hTAFII170
amino terminus contacts the concave surface of TBP.
Because Mot1 has been proposed to use a binding site on the convex
surface of yTBP overlapping with the TFIIA-binding site (1, 5, 6,
15) the possibility remained that the
hTAFII170 derivatives inhibited the TA complex by
binding competitively with TFIIA to hTBP. Under the gel mobility shift
conditions used, the hTBP-TATA complex was not stable enough to be
detected (data not shown). To clarify TFIIA involvement, the effects of
the hTAFII170 amino-terminal regions on hTBP-TATA
box complex formation in the absence of TFIIA were examined by DNase I
footprinting experiments. The analysis was first performed with hTBP
and a DNA probe that included the AdMLP TATA box in the presence of
purified GST-Flag-hTAFII170 region 2-460 (Fig.
7A). In the presence of saturating
amounts of hTBP, DNA was fully protected over the TATA box, indicating efficient binding of hTBP (Fig. 7A, lane 3). Addition of
hTAFII170 region 2-460 caused the hTBP footprint
to disappear in a dose-dependent manner, indicating that TBP was
displaced from the TATA box (Fig. 7A, lanes 4 to 7). Extended analysis
with region 290-381 also revealed displacement of hTBP (Fig. 7B, lanes
4 to 7). By contrast, hTAFII170 regions 2-137 and
380-460 failed to significantly inhibit hTBP binding to the TATA box
(data not shown). Together with the gel mobility shift data (Fig. 6),
these results show that subregion 290-381 of the amino-terminal region
2-460 is responsible for inhibiting the hTBP-TATA interaction by
blocking the concave DNA binding surface of hTBP.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 7.
The amino terminus of hTAFII170 inhibits the
TATA box-binding activity of hTBP. (A) DNase I footprinting was
performed with a AdMLP probe ( 17 to +33) and 6.0 pmol of His-hTBP in
the presence of GST-Flag-hTAFII170 residues 2 to 460 (lanes
4 to 7; 60, 30, 15, and 7.5 pmol, respectively). Lane 1, chemical
degradation of the probe on A + G's; lane 2, DNase I digestion of the
probe; lane 3, His-hTBP binding to the probe in the absence of
hTAFII170 2-460. Protected regions over the TATA box are
indicated by brackets. (B) DNase I footprinting was performed as
described for panel A in the presence of GST-Flag-hTAFII170
residues 290 to 381 (lanes 4 to 7; 44, 22, 11, and 5.5 pmol,
respectively). Lane 1, chemical degradation of the probe on A + G's;
lane 2, DNase I digestion of the probe; lane 3, His-hTBP binding to the
probe in the absence of hTAFII170 290-381. Protected
regions over the TATA box are indicated by brackets.
|
|
The amino-terminal regions of hTAFII170 inhibit RNA pol
II transcription in vitro.
The full-length yMot1 (D1408N)
mutant and yMot1 amino-terminal fragments whose ATPase activity has
been abolished act as dominant negatives by forming stable dead-end
complexes with yTBP (1, 8). The ability of the isolated
290-381 region of hTAFII170 to inhibit hTBP-TATA
interaction by blocking the concave surface of hTBP suggests that these
regions could also act in a dominant-negative fashion to inhibit in
vitro transcription by binding and sequestering hTBP. To test this
idea, hTBP binding regions 2-460 and 290-381 were added to a
reconstituted pol II transcription system dependent upon hTBP. In vitro
transcription reactions were reconstituted with bacterially derived
hTBP, TFIIB, and TFIIE; baculovirus-expressed TFIIF; purified HeLa
cell-derived TFIIH; and immunoaffinity-purified calf thymus pol II (see
Materials and Methods). Transcription was analyzed from a linearized
AdMLP core promoter (
53 to +10) that drives transcription of a 380-bp
guanosine (G)-less cassette. Addition of equivalent amounts of
purified GST-Flag-hTAFII170 region 2-460 or
290-381 to the reactions decreased transcription from the AdMLP (Fig.
8, lanes 2 to 4 and 8 to 10).
Quantitation of transcript levels corrected by using a labeled internal
standard RNA indicated that the regions 2-460 and 290-381 repressed pol II transcription by approximately 1.6 and 3.0-fold, respectively, at
the highest amount used (Fig. 8, lanes 2 and 8). The stronger inhibition seen with the 290-381 region correlates well with its ability to bind hTBP more strongly, inhibit the
dTAFII230/hTBP interaction, and inhibit hTBP-TATA
complex formation, compared to region 2-460. Notably, the effect of
these regions in transcription is less pronounced than that observed in
the gel mobility shift and DNase I footprint analyses (Fig. 6 and 7).
Possibly basal transcription factors present in the transcription
reactions can partially relieve the
hTAFII170-mediated inhibition (see Discussion). As expected, the weak TBP-binding region 2-137 had little or no effect
(Fig. 8, lanes 5 to 7). These results indicate that pol II
transcription can be directly repressed by region 290-381 of hTAFII170. This is consistent with the view that
this region is capable of inhibiting the hTBP-TATA interaction by
directly blocking the DNA binding surface of hTBP.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 8.
The amino terminus of hTAFII170 inhibits pol
II transcription. In vitro transcription reactions were performed as
described in Materials and Methods in the absence (lane 1) or presence
of GST-Flag-hTAFII170 residues 2 to 460 (lanes 2 to 4), 2 to 137 (lanes 5 to 7), or 290 to 381 (lanes 8 to 10). An equivalent
amount of each GST-Flag-hTAFII170 protein was used (46, 28, and 14 pmol for each titration series). Positions of comigrated DNA
size marker fragments are indicated on the left.
|
|
 |
DISCUSSION |
The basal transcription factor B-TFIID supports pol II
transcription as efficiently as TBP or TFIID in reconstituted basal transcription assays (49). However, in contrast to TBP or
TFIID, B-TFIID displays dynamic binding to the TATA box. In an effort to understand the apparent high on and off rates of B-TFIID for DNA
binding, we analyzed the interaction regions of its hTBP and hTAFII170 constituents. Our analysis indicates
that the concave surface of TBP responsible for DNA binding is an
important determinant for hTAFII170 action.
Our biochemical analyses mapped hTBP-binding domains in
hTAFII170 to three regions within its
amino-terminal third: residues 2 to 137, 290 to 381, and 380 to 460. The stable interaction of these regions with hTBP at increasing salt
concentrations (300 to 600 mM) suggests that the interaction of the
amino terminus of hTAFII170 with hTBP is
sustained mainly by hydrophobic interactions. These regions are also
important in the context of full-length hTAFII170, as we were unable to
coimmunoprecipitate hTBP and full-length hTAFII170 from cell extracts when these regions
were removed (data not shown). Yeast two-hybrid analysis indicated that
the hTAFII170 ATPase domain alone is unable to
interact detectably with hTBP. In addition we were also unable to
coimmunoprecipitate hTBP and the isolated
hTAFII170 ATPase domain from
cellular extracts (data not shown). Consistent with this, the Mot1
ATPase domain cannot bind yTBP in the absence or presence of DNA
(1, 2, 8). Together our results fit with the suggestion
that the ATPase domain of hTAFII170-related
proteins like Mot1 is targeted to its TBP substrate via the amino
terminus (6, 8).
The importance of the hTAFII170 amino-terminal
regions in contacting hTBP is consistent with previous findings that
the first 800 residues of Mot1 are responsible for binding yTBP
(1, 8). Furthermore, in the
hTAFII170 ortholog, Drosophila 89B
helicase (21), the first 825 residues can bind to dTBP
(1). The corresponding TBP-binding regions in
hTAFII170, Mot1, and 89B helicase also share
common, highly related blocks (Fig. 3A). These observations indicate
that the role of the amino terminus of hTAFII170
orthologs in TBP binding has been conserved during evolution.
Furthermore, recent computational analysis indicated that these regions
of hTAFII170 and Mot1 share clusters of tandemly
arrayed HEAT repeats (4, 40).
hTAFII170 contains six HEAT repeats within the
first 460 residues. A pair of predicted HEAT repeats of
hTAFII170 overlap with each of its TBP-binding
regions (Fig. 3A and B). Together this suggests that the HEAT repeat
protein motifs mediate TBP interaction in
hTAFII170 orthologs.
Our results show that the amino-terminal regions of
hTAFII170 exhibit species-specific interactions
with TBP family members. While hTAFII170 region
2-460 interacted with yTBP remarkably well, when individually assayed
the TBP-interacting regions showed poor binding. This may relate to
specific differences between yTBP and hTBP. The binding of
hTAFII170 region 290-381 to dTRF-1 suggests a
functional link between 89B helicase (21) and dTRF-1
(47). Consistent with this, residues 1 to 825 of 89B
helicase can bind dTRF-1 (1). This latter protein plays a
role in directing transcription by RNA pol III (47). In
this context it is interesting that hTAFII170 has
been linked to RNA pol III transcription in vitro (46).
However, other biochemical and genetic analyses have failed to observe
an involvement of B-TFIID and Mot1 in pol III transcription (6,
37).
The most striking finding of our analyses is that an amino-terminal
region of hTAFII170 can target the DNA binding
concave surface of hTBP. First, we have not only shown that
hTBPAS does not bind efficiently to the amino
terminus of hTAFII170 or to full-length
hTAFII170 in vivo but also that the region
290-381 of hTAFII170 can compete with
dTAFII230 (TAND I) for binding the concave face
of hTBP. Second, our biochemical evidence clearly shows that both
regions 2-460 and 290-381 can inhibit hTBP-TATA box interaction.
Notably, the effect of the hTAFII170 regions 2-460 and 290-381 in TATA-dependent in vitro transcription was less
pronounced, in spite of the strong effect that they had on TBP-TATA
complex formation in gel mobility shift and DNase I footprinting analyses. It is possible that stabilization of the TBP-TATA interaction by basal transcription factors such as TFIIA, TFIIB, and TFIIE (27, 51) partially counteracts the repressing activity of this hTAFII170 region. Alternatively, the effects
of TFIIA, TFIIB, or TFIIE may be attributable to a block of
hTAFII170 interaction with hTBP. Thirdly, the
hTBPAS-TATA box interaction is less sensitive to
inhibition by the hTAFII170 amino terminus.
Together these results provide a rationale for the previous observation
that B-TFIID cannot bind stably to the TATA box (49).
Region 290-381 of hTAFII170 can compete with the
TATA box for interaction with the concave DNA binding surface of hTBP.
This is supported by the recent observations of Darst and coworkers
(19) that preincubation of Mot1 with yTBP off DNA inhibits
subsequent DNA binding by yTBP.
Previous mutational analyses indicate that amino acid residues of the
yTBP H2 convex surface are important for the interaction between yTBP
and Mot1 (1, 15). Furthermore, TFIIA has been shown to
bind to H2 of the convex surface of yTBP competitively with Mot1
(5, 6, 15). Our observation that a single mutation at K243
of hTBP severely disrupts binding of full-length
hTAFII170 in vivo suggests that
hTAFII170 also interacts with the convex surface
of hTBP. Together, with our observation that
hTAFII170 binds the concave surface of hTBP,
these results suggest that hTAFII170 can interact
with multiple surfaces of hTBP. The behavior of
hTAFII170 regions 2-137 and 380-460 was distinct
from that of 2-460 and 290-381. Both bound to hTBP but had relatively
minor, if any effects, on dTAFII230/TBP or
TBP-TATA interactions (Fig. 7 and 8; data not shown). This distinct
behavior may reflect an unstable interaction with the hTBP concave
surface. Alternatively, these regions may contact the convex surface of
hTBP. In that case one would expect higher-order complexes with these
regions in gel shift analyses. Although this was not observed, TFIIA
present to stabilize hTBP-TATA binding in these analyses may have
competed with hTAFII170 regions 2-137 and
380-460. Therefore, in this context we cannot conclude whether these
regions bind the hTBP convex surface.
It has been proposed that displacement of TBP from DNA by Mot1 involves
an ATP-driven power stroke which relieves a conformationally strained
Mot1 to pull the TBP-DNA complex apart (8). This was suggested to involve conformational changes in TBP (2).
Our findings imply a different mechanism for the regulation of the TBP-TATA interaction by hTAFII170/Mot1 and how
this relates to the TATA box-binding properties of B-TFIID. In its
simplest form we propose a model for B-TFIID function in which B-TFIID
can convert from an active to a blocked conformation and vice versa. In
the blocked conformation, access of TBP to promoter DNA would be
precluded by the presence of region 290-381 of
hTAFII170 in the DNA binding cavity of TBP. This
would explain the inability of B-TFIID to stably interact with TATA box
DNA (49). In the active conformation, region 290-381 is
absent from the concave surface and TBP is free to interact with
promoter DNA. The ability of B-TFIID to support TATA-dependent
transcription (49) could reflect this conformation. In
this respect it is important to determine whether
hTAFII170/Mot1 is still associated with TBP when
the latter is bound to active promoters. Alternatively,
hTAFII170/Mot1 may dissociate when TBP is
assembled into an active preinitiation complex. An essential feature of
our proposed model would be conversion between the active and blocked
states. It is likely that the ATPase function of
hTAFII170/Mot1 is involved in this conversion. As
mentioned, dissociation of preformed TBP-TATA complexes by
hTAFII170/Mot1 requires ATP hydrolysis (5,
6, 16). Future work using mutagenesis and single-molecule
studies is required to more directly test these possibilities.
hTAFII170 shows the same pattern of TBP-TATA
complex inhibition as dTAFII230 and
yTAFII145/130 in gel mobility shift, DNase I
footprint, and in vitro transcription analyses (31, 33). Furthermore, TBPAS residues affecting
hTAFII170 binding contact dTAFII230 (34). These results
support the concept that occupancy of the TBP concave surface may be a
general mechanism for TAFII regulation of TBP-DNA
binding. Most TBP is associated with other proteins in the cell
(44, 49). Given the present results, it seems that several
TBP/TAF complexes have a built-in module that regulates TBP access to
DNA to prevent spurious TATA-DNA interactions. Negative regulation of
TBP-binding activity may therefore be a general conserved property of
TBP/TAF complexes. This appears relevant given that TBP has a
relatively high affinity for nonpromoter DNA (23).
Additionally, the weak consensus for the TATA element results in
numerous nonpromoter binding sites for TBP within the genome.
Consistent with this view, TAFI48 of SL1 can
prevent binding of TBP to the TATA box element of pol I promoters
(12). Furthermore, the association of TBP with the SAGA
subunits Spt3 and Spt8 regulates TBP-DNA binding (13). Reversibility of this concave inhibition would be a key feature to
allow TBP to bind DNA. It has been proposed that transcriptional activators like c-Jun, VP16, GAL4, and EBNA2 may regulate
dTAFII230/hTAFII250 inhibition of TBP binding to DNA (30, 32, 35, 41). Might hTAFII170 inhibition of TBP be similarly
modulated? While hTAFII170 does not respond to
activators tested so far (49), it may respond to other
activators or components of the general transcription apparatus
releasing its inhibition of TBP. Our present results provide a
framework for these studies.
 |
ACKNOWLEDGMENTS |
We thank A. Berk for the pSRaMSVtkneoTBPAS convex
mutants; H. Stunnenberg for pSG-ehTBP and pSG-ehTBPm3e; C. Kane for
pET22-TFIIS, Y. Nakatani for pGST-dTAFII230 (2-81),
pGST-dTAFII230 (82-156), and pGST-dTAFII230
(2-156); M. Rabenstein for pGST-dTRF-2; R. Romier for pACYC; L. Tora
for pGST-ceTLF; and N. Zak for pGST-dTBP. We are grateful to N. Zak for
communication of unpublished results. We acknowledge the contributions
of F. Holstege in providing TFIIH. We thank F. Kavelaars for technical
assistance and members of our laboratory for discussions and critical
reading of this manuscript.
This work was supported by a grant to H.T.M.T. from Human Sciences
Frontier Program Organization (HSFPO) and The Netherlands Organization
for Scientific Research-Medical Sciences (NWO-MW).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Physiological Chemistry, University Medical Center Utrecht, P.O. Box 85060, 3508 AB Utrecht, The Netherlands. Phone: 31-30-253-8981. Fax:
31-30-253-9035. E-mail: h.t.m.timmers{at}med.uu.nl.
Present address: Faculty of Medicine, Department of Molecular Cell
Biology, Leiden University, 2300 RA Leiden, The Netherlands.
Present address: Medical Genetics Centre, Erasmus University
Rotterdam, 3000 DR Rotterdam, The Netherlands.
§
Present address: Department of Gynecology, University Hospital
Groningen, 9700 RB Groningen, The Netherlands.
 |
REFERENCES |
| 1.
|
Adamkewicz, J. I.,
K. E. Hansen,
W. A. Prud'homme,
J. L. Davis, and J. Thorner.
2001.
High-affinity interaction of yeast transcriptional regulator, Mot1, with TATA box-binding protein (TBP).
J. Biol. Chem.
276:11883-11894[Abstract/Free Full Text].
|
| 2.
|
Adamkewicz, J. I.,
C. G. F. Mueller,
K. E. Hansen,
W. A. Prud'homme, and J. Thorner.
2000.
Purification and enzymatic properties of Mot1 ATPase, a regulator of basal transcription in the yeast Saccharomyces cerevisiae.
J. Biol. Chem.
275:21158-21168[Abstract/Free Full Text].
|
| 3.
|
Albright, S. R., and R. Tjian.
2000.
TAF's revisited: more data reveal new twists and confirm old ideas.
Gene
242:1-13[CrossRef][Medline].
|
| 4.
|
Andrade, M. A.,
C. Petosa,
S. I. O'Donoghue,
C. W. Muller, and P. Bork.
2001.
Comparison of ARM and HEAT protein repeats.
J. Mol. Biol.
309:1-18[CrossRef][Medline].
|
| 5.
|
Auble, D. T., and S. Hahn.
1993.
An ATP-dependent inhibitor of TBP binding to DNA.
Genes Dev.
7:844-856[Abstract/Free Full Text].
|
| 6.
|
Auble, D. T.,
K. E. Hansen,
C. G. F. Mueller,
W. S. Lane,
J. Thorner, and S. Hahn.
1994.
Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism.
Genes Dev.
8:1920-1934[Abstract/Free Full Text].
|
| 7.
|
Auble, D. T., and S. M. Steggerda.
1999.
Testing for DNA tracking by Mot1, a SNF2/SWI2 protein family member.
Mol. Cell. Biol.
19:412-423[Abstract/Free Full Text].
|
| 8.
|
Auble, D. T.,
D. Wang,
K. W. Post, and S. Hahn.
1997.
Molecular analysis of the SNF2/SWI2 protein family member Mot1, an ATP-driven enzyme that dissociates TATA-binding protein from DNA.
Mol. Cell. Biol
17:4842-4851[Abstract].
|
| 9.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl.
1992.
Short protocols in molecular biology.
John Wiley & Sons, New York, N.Y.
|
| 10.
|
Bagby, S.,
T. K. Mal,
D. Liu,
E. Raddatz,
Y. Nakatani, and M. Ikura.
2000.
TFIIA-TAF regulatory interplay: NMR evidence for overlapping binding sites on TBP.
FEBS Lett.
468:149-154[CrossRef][Medline].
|
| 11.
|
Bai, Y.,
G. M. Perez,
J. M. Beecham, and P. A. Weil.
1997.
Structure-function analysis of TAF130: identification and characterization of a high-affinity TATA-binding protein interaction domain in the N terminus of yeast TAFII130.
Mol. Cell. Biol.
17:3081-3093[Abstract].
|
| 12.
|
Beckmann, H.,
J.-L. Chen,
T. O'Brien, and R. Tjian.
1995.
Coactivator and promoter-selective properties of RNA polymerase I TAFs.
Science
270:1506-1509[Abstract/Free Full Text].
|
| 13.
|
Belotserkovskaya, R.,
D. E. Sterner,
M. Deng,
M. H. Sayre,
P. M. Lieberman, and S. L. Berger.
2000.
Inhibition of TATA-binding protein function by SAGA subunits Spt3 and Spt8 at Gcn4-activated promoters.
Mol. Cell. Biol.
20:634-647[Abstract/Free Full Text].
|
| 14.
|
Bryant, G. O.,
L. S. Martel,
S. K. Burley, and A. J. Berk.
1996.
Radical mutations reveal TATA-box binding protein surfaces required for activated transcription in vivo.
Genes Dev.
10:2491-2504[Abstract/Free Full Text].
|
| 15.
|
Cang, Y.,
D. T. Auble, and G. Prelich.
1999.
A new regulatory domain on the TATA-binding protein.
EMBO J.
18:6662-6671[CrossRef][Medline].
|
| 16.
|
Chicca, J. J., II,
D. T. Auble, and B. F. Pugh.
1998.
Cloning and biochemical characterization of TAF-172, a human homolog of yeast Mot1.
Mol. Cell. Biol.
18:1701-1710[Abstract/Free Full Text].
|
| 17.
|
Collart, M. A.
1996.
The NOT, SPT3, and MOT1 genes functionally interact to regulate transcription at core promoters.
Mol. Cell. Biol.
16:6668-6676[Abstract].
|
| 18.
|
Dantonel, J.-C.,
J.-M. Wurtz,
O. Poch,
D. Moras, and L. Tora.
1999.
The TBP-like factor: an alternative transcription factor in metazoa?
Trends Biochem. Sci
285:335-339.
|
| 19.
|
Darst, R. P.,
D. Wang, and D. T. Auble.
2001.
MOT1-catalyzed TBP-DNA disruption: uncoupling DNA conformational change and role of upstream DNA.
EMBO J.
20:2028-2040[CrossRef][Medline].
|
| 20.
|
Davis, J. L.,
R. Kunisawa, and J. Thorner.
1992.
A presumptive helicase (MOT1 gene product) affects gene expression and is required for viability in the yeast Saccharomyces cerevisiae.
Mol. Cell. Biol.
12:1879-1892[Abstract/Free Full Text].
|
| 21.
|
Goldman-Levi, R.,
C. Miller,
J. Bogoch, and N. B. Zak.
1996.
Expanding the mot1 subfamily: 89B helicase encodes a new Drosophila melanogaster SNF2-related protein which binds to multiple site on polytene chromosomes.
Nucleic Acids Res.
24:3121-3128[Abstract/Free Full Text].
|
| 22.
|
Groves, M. R.,
N. Hanlon,
P. Turowski,
B. A. Hemmings, and D. Barford.
1999.
The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs.
Cell
96:99-110[CrossRef][Medline].
|
| 23.
|
Hahn, S.,
S. Buratowski,
P. A. Sharp, and L. Guarente.
1989.
Yeast TATA-binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences.
Proc. Natl. Acad. Sci. USA
86:5718-5722[Abstract/Free Full Text].
|
| 24.
|
Hampsey, M.
1998.
Molecular genetics of the RNA polymerase II general transcriptional machinery.
Microbiol. Mol. Biol. Rev.
62:465-503[Abstract/Free Full Text].
|
| 25.
|
Hernandez, N.
1993.
TBP, a universal eukaryotic transcription factor?
Genes Dev.
7:1291-1308[Free Full Text].
|
| 26.
|
Holstege, F. C. P.,
P. C. van der Vliet, and H. T. M. Timmers.
1996.
Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH.
EMBO J.
15:1666-1677[Medline].
|
| 27.
|
Kang, J. J.,
D. T. Auble,
J. A. Ranish, and S. Hahn.
1995.
Analysis of the yeast factor TFIIA: distinct functional regions and a polymerase II-specific role in basal and activated transcription.
Mol. Cell. Biol.
15:1234-1243[Abstract].
|
| 28.
|
Kim, J. L.,
D. B. Nikolov, and S. K. Burley.
1993.
Co-crystal structure of TBP recognizing the minor groove of a TATA element.
Nature
365:520-527[CrossRef][Medline].
|
| 29.
|
Kim, Y.,
J. H. Geiger,
S. Hahn, and P. B. Sigler.
1993.
Crystal structure of a yeast TBP/TATA-box complex.
Nature
365:512-520[CrossRef][Medline].
|
| 30.
|
Kobayashi, A.,
T. Miyake,
Y. Ohyama,
M. Kawaichi, and T. Kokubo.
2000.
Mutations in the TATA-binding protein, affecting transcriptional activation, show synthetic lethality with the TAF145 gene lacking the TAF N-terminal domain in Saccharomyces cerevisiae.
J. Biol. Chem.
276:395-405[Abstract/Free Full Text].
|
| 31.
|
Kokubo, T.,
S. Yamashita,
M. Horikoshi,
R. G. Roeder, and Y. Nakatani.
1994.
Interaction between the N-terminal domain of the 230-kDa subunit and the TATA box-binding subunit of TFIID negatively regulates TATA-box binding.
Proc. Natl. Acad. Sci. USA
91:3520-3524[Abstract/Free Full Text].
|
| 32.
|
Kotani, T.,
K.-I. Banno,
M. Ikura,
A. G. Hinnebusch,
Y. Nakatani,
M. Kawaichi, and T. Kokubo.
2000.
A role of transcriptional activators as antirepressors for the autoinhibitory activity of TATA box binding transcription factor IID.
Proc. Natl. Acad. Sci. USA
97:7178-7183[Abstract/Free Full Text].
|
| 33.
|
Kotani, T.,
T. Miyake,
Y. Tsukihashi,
A. G. Hinnebusch,
Y. Nakatani,
M. Kawaichi, and T. Kokubo.
1998.
Identification of highly conserved amino-terminal segments of dTAFII230 and yTAFII145 that are functionally interchangeable for inhibiting TBP-DNA interactions in vitro and in promoting yeast cell growth in vivo.
J. Biol. Chem.
273:32254-32264[Abstract/Free Full Text].
|
| 34.
|
Liu, D.,
R. Ishima,
K. I. Tong,
S. Bagby,
T. Kokubo,
D. R. Muhandiram,
L. E. Kay,
Y. Nakatani, and M. Ikura.
1998.
Solution structure of a TBP-TAFII230 complex: protein mimicry of the minor groove surface of the TATA box unwound by TBP.
Cell
94:573-583[CrossRef][Medline].
|
| 35.
|
Lively, T. N.,
H. A. Ferguson,
S. K. Galasinski,
A. G. Seto, and J. A. Goodrich.
2001.
c-Jun binds the N terminus of human TAFII250 to derepres |